Lineage Cell Therapeutics (LCTX) Other Operating Expenses (2010 - 2025)
Lineage Cell Therapeutics' (LCTX) quarterly Other Operating Expenses came in at $66000.0 in Q4 2025, down 57.14% year-on-year from $154000.0 in Q4 2024, and up 1220.0% quarter-over-quarter from $5000.0 in Q3 2025.
Lineage Cell Therapeutics (LCTX) Other Operating Expenses (2010 - 2025) Analysis & Trends
Lineage Cell Therapeutics' Other Operating Expenses history runs 11 years deep, the most recent figure standing at $66000.0 for Q4 2025.
- On a quarterly basis, Other Operating Expenses fell 57.14% year-over-year to $66000.0 in Q4 2025; TTM through Mar 2026 was $15.0 million, a 5396.32% increase from a year earlier, with the FY2025 full-year figure at $15.0 million, up 4386.83% from the prior year.
- Other Operating Expenses rose to $66000.0 in Q4 2025 per LCTX's latest filing, from $5000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $14.9 million in Q2 2025 and bottomed at $5000.0 in Q3 2025.
- The 3-year median for Other Operating Expenses is $98000.0 (2024), against an average of $1.4 million.
- Biggest YoY gain for Other Operating Expenses was 33715.91% in 2025; the steepest drop was 86.84% in 2025.
- Year by year, Other Operating Expenses stood at $169000.0 in 2023, then fell by 8.88% to $154000.0 in 2024, then plunged by 57.14% to $66000.0 in 2025.
- Per Business Quant, the three latest LCTX Other Operating Expenses figures stand at $66000.0 (Q4 2025), $5000.0 (Q3 2025), and $14.9 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 14.88 Mn |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Sep 30, 2023 | 169,000.00 |
| Jun 30, 2023 | 127,000.00 |
| Mar 31, 2023 | 119,000.00 |
| Dec 31, 2018 | -108,000.00 |
| Mar 31, 2018 | 800,000.00 |
| Jun 30, 2017 | 1.75 Mn |
| Dec 31, 2015 | 2,000.00 |
| Dec 31, 2014 | -217.00 |
| Sep 30, 2014 | -133.00 |
| Mar 31, 2014 | -8,576.00 |
| Sep 30, 2013 | 5,830.00 |
| Jun 30, 2013 | 800.00 |